This bill amends the Controlled Substance, Drug, Device and Cosmetic Act, specifically focusing on drug overdose medication. It updates Section 13.8(a)(1) to expand the scope of practice for emergency medical services providers by allowing them to administer an opioid antagonist. The new legal language includes the specific mention of "naloxone and nalmefene" as approved opioid antagonists that can be administered in prehospital settings.

The bill aims to enhance the response capabilities of emergency medical services in addressing opioid overdoses, thereby potentially saving lives. It is set to take effect 60 days after its enactment, reflecting the urgency of improving access to life-saving medications in emergency situations.

Statutes/Laws affected:
Printer's No. 2836 (Jan 30, 2026): P.L.233, No.64